2096:HKG
Simcere Pharmaceutical Group Ltd
11,02 HKD
arrow_upward
+1,75%(+0,19) 1D
16. lis, 16:08:14 GMT+8 · HKD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za 2096...
Otvori
10,85 HKD
Najviša
11,29 HKD
Najniža
10,85 HKD
Trž. kap.
28,30 mlr.
Prosj. kol.
4,02 mil.
Količina
5,80 mil.
Dividenda
1,88 %
Kvartalna dividenda
0,05 HKD
Datum nakon isplate dividende
18. lip 2025.
P/E omjer
16,54
52-tjed. najviša
14,38 HKD
52-tjed. najniža
9,07 HKD
EPS
0,67 HKD
Dionice u optjecaju
2,57 mlr.
Broj djelatnika
7 tis.
Otvori
10,85 HKD
Najviša
11,29 HKD
Najniža
10,85 HKD
Trž. kap.
28,30 mlr.
Prosj. kol.
4,02 mil.
Količina
5,80 mil.
Dividenda
1,88 %
Kvartalna dividenda
0,05 HKD
Datum nakon isplate dividende
18. lip 2025.
P/E omjer
16,54
52-tjed. najviša
14,38 HKD
52-tjed. najniža
9,07 HKD
EPS
0,67 HKD
Dionice u optjecaju
2,57 mlr.
Broj djelatnika
7 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
Financije.hr
·
prije 2 dana
Wall Street pred otvaranjem: Rotacija iz tehnologije jača, Dow preuzima vodstvo
AskTraders.com
·
prije 1 sat
S&P 500 Can Absorb Fed Hikes, Says UBS CIO After Hot US Inflation
Traders Union
·
prije 1 sat
Peter Tuchman: Nasdaq posts worst week since April 2025 tariff selloff as S&P 500 loses $1.3 trillion
Yahoo Finance
·
prije 10 sati
Michael Burry Warns of a Stock Market ‘Supervolcano’
Profil
Simcere Pharmaceutical Group or Simcere Pharmaceutical is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. Its focus is to introduce generic and pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate. The company has introduced a generic anti-stroke medication under the brand name, Bicun, and an anti-cancer medication under the brand name, Endu. Its products include antibiotics, anti-stroke medications, anti-inflammatory drugs, anti-cancer medications and other medicines. In addition, it has obtained approvals from the China State Food and Drug Administration to manufacture and sell over 210 other products. Wikipedia
Simcere Pharmaceutical Group Ltd – informacije
Glavni izvršni direktorRen Jinsheng
Zaposlenici7,06 tis.
Osnovano1995
SjedišteNanjing, Jiangsu, Kina
Sektor-
Web-lokacijasimcere.com